Currently, there are highly accurate cerebrospinal fluid (CSF) and plasma AD biomarkers, including amyloid beta 42 (Aβ42)6, phosphorylated tau at threonine-217 (pTau217), and pTau1817. The gene discussed is MAPT; the disease is Alzheimer disease.